Medicines Development for Global Health Achieves Key Milestone with Landmark Approval of Moxidectin in Ghana
Medicines Development for Global Health (MDGH) announced today that the Ghana Food and Drugs Authority has approved moxidectin 2 mg oral tablets for the treatment of river blindness (onchocerciasis) in adults and children aged four years and older. This marks…
Read more
